 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
8 terms
|
 |
|
Biological process
|
metabolic process
|
24 terms
|
 |
|
Biochemical function
|
nucleic acid binding
|
14 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
285:1209-1233
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
|
|
D.D.Leonidas,
R.Shapiro,
S.C.Allen,
G.V.Subbarao,
K.Veluraja,
K.R.Acharya.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human angiogenin (Ang), an unusual member of the pancreatic RNase superfamily,
is a potent inducer of angiogenesis in vivo. Its ribonucleolytic activity is
weak (10(4) to 10(6)-fold lower than that of bovine RNase A), but nonetheless
seems to be essential for biological function. Ang has been implicated in the
establishment of a wide range of human tumours and has therefore emerged as an
important target for the design of new anti-cancer compounds. We report
high-resolution crystal structures for native Ang in two different forms (Pyr1
at 1.8 A and Met-1 at 2.0 A resolution) and for two active-site variants, K40Q
and H13A, at 2.0 A resolution. The native structures, together with earlier
mutational and biochemical data, provide a basis for understanding the unique
functional properties of this molecule. The major structural features that
underlie the weakness of angiogenin's RNase activity include: (i) the
obstruction of the pyrimidine-binding site by Gln117; (ii) the existence of a
hydrogen bond between Thr44 and Thr80 that further suppresses the effectiveness
of the pyrimidine site; (iii) the absence of a counterpart for the His119-Asp121
hydrogen bond that potentiates catalysis in RNase A (the corresponding aspartate
in Ang, Asp116, has been recruited to stabilise the blockage of the pyrimidine
site); and (iv) the absence of any precise structural counterparts for two
important purine-binding residues of RNase A. Analysis of the native structures
has revealed details of the cell-binding region and nuclear localisation signal
of Ang that are critical for angiogenicity. The cell-binding site differs
dramatically from the corresponding regions of RNase A and two other homologues,
eosinophil-derived neurotoxin and onconase, all of which lack angiogenic
activity. Determination of the structures of the catalytically inactive variants
K40Q and H13A has now allowed a rigorous assessment of the relationship between
the ribonucleolytic and biological activities of Ang. No significant change
outside the enzymatic active site was observed in K40Q, establishing that the
loss of angiogenic activity for this derivative is directly attributable to
disruption of the catalytic apparatus. The H13A structure shows some changes
beyond the ribonucleolytic site, but sites involved in cell-binding and nuclear
translocation are essentially unaffected by the amino acid replacement.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. A representation of the Ang structure. The disulphide bonds are shown in ball-and-stick representation.
The inset presents the details of the Ang ribonucleolytic active site including water molecules (in blue). The amino
acid residues are shown in standard colour. Broken lines represent hydrogen bonds.
|
 |
Figure 10.
Figure 10. Stereo view of the superimposed C
a
back-
bones of native Ang (Pyr1 form, black) onto those of
K40Q (green) and H13A (red).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1999,
285,
1209-1233)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Sadagopan,
N.Sharma-Walia,
M.V.Veettil,
V.Bottero,
R.Levine,
R.J.Vart,
and
B.Chandran
(2009).
Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis.
|
| |
J Virol, 83,
3342-3364.
|
 |
|
|
|
|
 |
K.Kazakou,
D.E.Holloway,
S.H.Prior,
V.Subramanian,
and
K.R.Acharya
(2008).
Ribonuclease A homologues of the zebrafish: polymorphism, crystal structures of two representatives and their evolutionary implications.
|
| |
J Mol Biol, 380,
206-222.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Dell'Orco,
P.G.De Benedetti,
and
F.Fanelli
(2007).
In silico screening of mutational effects on enzyme-proteic inhibitor affinity: a docking-based approach.
|
| |
BMC Struct Biol, 7,
37.
|
 |
|
|
|
|
 |
D.S.Osorio,
A.Antunes,
and
M.J.Ramos
(2007).
Structural and functional implications of positive selection at the primate angiogenin gene.
|
| |
BMC Evol Biol, 7,
167.
|
 |
|
|
|
|
 |
E.Boix,
and
M.V.Nogués
(2007).
Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence.
|
| |
Mol Biosyst, 3,
317-335.
|
 |
|
|
|
|
 |
H.T.Chang,
T.W.Pai,
T.C.Fan,
B.H.Su,
P.C.Wu,
C.Y.Tang,
C.T.Chang,
S.H.Liu,
and
M.D.Chang
(2006).
A reinforced merging methodology for mapping unique peptide motifs in members of protein families.
|
| |
BMC Bioinformatics, 7,
38.
|
 |
|
|
|
|
 |
D.E.Holloway,
G.B.Chavali,
M.C.Hares,
V.Subramanian,
and
K.R.Acharya
(2005).
Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies.
|
| |
Acta Crystallogr D Biol Crystallogr, 61,
1568-1578.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.S.Sanjeev,
and
S.Vishveshwara
(2004).
Protein-water interactions in ribonuclease A and angiogenin: a molecular dynamics study.
|
| |
Proteins, 55,
915-923.
|
 |
|
|
|
|
 |
A.Merlino,
L.Vitagliano,
M.A.Ceruso,
and
L.Mazzarella
(2003).
Subtle functional collective motions in pancreatic-like ribonucleases: from ribonuclease A to angiogenin.
|
| |
Proteins, 53,
101-110.
|
 |
|
|
|
|
 |
G.B.Chavali,
A.C.Papageorgiou,
K.A.Olson,
J.W.Fett,
G.Hu,
R.Shapiro,
and
K.R.Acharya
(2003).
The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody.
|
| |
Structure, 11,
875-885.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.L.Jenkins,
R.Y.Kao,
and
R.Shapiro
(2003).
Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
|
| |
Proteins, 50,
81-93.
|
 |
|
|
|
|
 |
G.J.Swaminathan,
D.E.Holloway,
K.Veluraja,
and
K.R.Acharya
(2002).
Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin.
|
| |
Biochemistry, 41,
3341-3352.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Y.Kao,
J.L.Jenkins,
K.A.Olson,
M.E.Key,
J.W.Fett,
and
R.Shapiro
(2002).
A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity.
|
| |
Proc Natl Acad Sci U S A, 99,
10066-10071.
|
 |
|
|
|
|
 |
D.D.Leonidas,
G.B.Chavali,
A.M.Jardine,
S.Li,
R.Shapiro,
and
K.R.Acharya
(2001).
Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography.
|
| |
Protein Sci, 10,
1669-1676.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.S.Madhusudhan,
B.S.Sanjeev,
and
S.Vishveshwara
(2001).
Computer modeling and molecular dynamics simulations of ligand bound complexes of bovine angiogenin: dinucleotide topology at the active site of RNase a family proteins.
|
| |
Proteins, 45,
30-39.
|
 |
|
|
|
|
 |
M.S.Madhusudhan,
and
S.Vishveshwara
(2001).
Computer modeling of human angiogenin-dinucleotide substrate interaction.
|
| |
Proteins, 42,
125-135.
|
 |
|
|
|
|
 |
N.E.Robinson,
and
A.B.Robinson
(2001).
Prediction of protein deamidation rates from primary and three-dimensional structure.
|
| |
Proc Natl Acad Sci U S A, 98,
4367-4372.
|
 |
|
|
|
|
 |
K.Tomita,
T.Ogawa,
T.Uozumi,
K.Watanabe,
and
H.Masaki
(2000).
A cytotoxic ribonuclease which specifically cleaves four isoaccepting arginine tRNAs at their anticodon loops.
|
| |
Proc Natl Acad Sci U S A, 97,
8278-8283.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|